Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.lfs.2020.117788 http://scihub22266oqcxt.onion/10.1016/j.lfs.2020.117788 32475810!7219356!32475810     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32475810&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Life+Sci 2020 ; 254 (ä): 117788 Nephropedia Template TP {{tp|p=32475810|t=2020. The role of biomarkers in diagnosis of COVID-19 - A systematic review |pdf=|usr=}}{{32475810}} gab.com Text The role of biomarkers in diagnosis of COVID-19 - A systematic review JO: Life Sci http://www.kidney.de/pget.php?&tw=1&pmid=32475810 #FOAvip AIMS: As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries and affected over three million confirmed people. We review different biomarkers to evaluate if they are able to predict clinical outcomes and correlate with the severity of COVID-19 disease. METHODS: A systematic review of the literature was carried out to identify relevant articles using six different databases. Keywords to refine the search included 'COVID-19', 'SARS-CoV2', 'Biomarkers', among others. Only studies which reported data on pre-defined outcomes were included. KEY FINDINGS: Thirty-four relevant articles were identified which reviewed the following biomarkers: C-reactive protein, serum amyloid A, interleukin-6, lactate dehydrogenase, neutrophil-to-lymphocyte ratio, D-dimer, cardiac troponin, renal biomarkers, lymphocytes and platelet count. Of these, all but two, showed significantly higher levels in patients with severe complications of COVID-19 infection compared to their non-severe counterparts. Lymphocytes and platelet count showed significantly lower levels in severe patients compared to non-severe patients. SIGNIFICANCE: Although research is still in its early stages, the discovery of how different biomarkers behave during the course of the disease could help clinicians in identifying severe disease earlier and subsequently improve prognosis. Nevertheless, we urge for more research across the globe to corroborate these findings. Twit Text FOAVip The role of biomarkers in diagnosis of COVID-19 - A systematic review ????Life Sci http://www.kidney.de/pget.php?&tw=1&pmid=32475810 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32475810 #FOAvip English Wikipedia <ref>{{Cite pmid|32475810}}</ref> The role of biomarkers in diagnosis of COVID-19 - A systematic review #MMPMID32475810 Kermali M; Khalsa RK; Pillai K; Ismail Z; Harky A Life Sci 2020[Aug]; 254 (ä): 117788 PMID32475810show ga AIMS: As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries and affected over three million confirmed people. We review different biomarkers to evaluate if they are able to predict clinical outcomes and correlate with the severity of COVID-19 disease. METHODS: A systematic review of the literature was carried out to identify relevant articles using six different databases. Keywords to refine the search included 'COVID-19', 'SARS-CoV2', 'Biomarkers', among others. Only studies which reported data on pre-defined outcomes were included. KEY FINDINGS: Thirty-four relevant articles were identified which reviewed the following biomarkers: C-reactive protein, serum amyloid A, interleukin-6, lactate dehydrogenase, neutrophil-to-lymphocyte ratio, D-dimer, cardiac troponin, renal biomarkers, lymphocytes and platelet count. Of these, all but two, showed significantly higher levels in patients with severe complications of COVID-19 infection compared to their non-severe counterparts. Lymphocytes and platelet count showed significantly lower levels in severe patients compared to non-severe patients. SIGNIFICANCE: Although research is still in its early stages, the discovery of how different biomarkers behave during the course of the disease could help clinicians in identifying severe disease earlier and subsequently improve prognosis. Nevertheless, we urge for more research across the globe to corroborate these findings. |Betacoronavirus[MESH] |Biomarkers[MESH] |C-Reactive Protein/analysis[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques[MESH] |Coronavirus Infections/*diagnosis[MESH] |Fibrin Fibrinogen Degradation Products/analysis[MESH] |Humans[MESH] |Interleukin-6/blood[MESH] |Kidney[MESH] |L-Lactate Dehydrogenase/blood[MESH] |Lymphocyte Count[MESH] |Neutrophils/cytology[MESH] |Pandemics[MESH] |Platelet Count[MESH] |Pneumonia, Viral/*diagnosis[MESH] |Prognosis[MESH] |SARS-CoV-2[MESH] |Serum Amyloid A Protein/analysis[MESH]The role of biomarkers in diagnosis of COVID-19 - A systematic review (epmc).pdf DeepDyve Pubget Overpricing